These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 25323488)

  • 1. Autoantibodies against β1 receptor and AT1 receptor in type 2 diabetes patients with left ventricular dilatation.
    Zhao L; Xu C; Xu J
    Cardiology; 2014; 129(3):191-6. PubMed ID: 25323488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical evaluation of valsartan and metoprolol tartrate in treatment of diabetic nephropathy with positive β1-adrenergic and anti-angiotensin II type 1 receptor antibody.
    Zhao LS; Bai WW; Xiang GD; Yue L; Sun HL
    Chin Med J (Engl); 2012 Oct; 125(19):3543-7. PubMed ID: 23044321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Positive rate of autoantibodies against adrenergic receptors beta1 and angiotensin II type 1 receptors in the type 2 diabetes mellitus with or without hypertension].
    Zhao LS; Liao YH; Xiang GD; Wang M; Yue L; Zhou ZH; Sun HL
    Zhonghua Xin Xue Guan Bing Za Zhi; 2010 Feb; 38(2):139-42. PubMed ID: 20398560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoantibodies in type 2 diabetes patients with left ventricular dilatation: biomarkers and/or risk markers?
    Landsberger M
    Cardiology; 2014; 129(3):189-90. PubMed ID: 25323426
    [No Abstract]   [Full Text] [Related]  

  • 5. Questionable Validity of Peptide-Based ELISA Strategies in the Diagnostics of Cardiopathogenic Autoantibodies That Activate G-Protein-Coupled Receptors.
    Jahns R; Boege F
    Cardiology; 2015; 131(3):149-50. PubMed ID: 25926265
    [No Abstract]   [Full Text] [Related]  

  • 6. [The relation between positive rate of autoantibodies against beta1 and M2-adrenergic receptors and urinary albumin excretion rate in the type 2 diabetes mellitus with refractory hypertension].
    Zhao LS; Liao YH; Xiang GD; Wang M; LE L; Zhou ZH; Lin X; Sun HL
    Zhonghua Xin Xue Guan Bing Za Zhi; 2008 Jun; 36(6):527-30. PubMed ID: 19100067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Association between positive autoantibodies against AT1-receptor and cardiac remodeling in patients with hypertension].
    Qiu Y; Zhu F; Liao YH; Li ZZ; Wang M
    Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Dec; 35(12):1141-4. PubMed ID: 18341819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of the angiotensin II antagonist valsartan on left ventricular hypertrophy in patients with essential hypertension.
    Gottdiener JS
    Circulation; 1999 Aug; 100(6):685-6. PubMed ID: 10490345
    [No Abstract]   [Full Text] [Related]  

  • 9. Influence of autoantibodies against AT1 receptor and AGTR1 polymorphisms on candesartan-based antihypertensive regimen: results from the study of optimal treatment in hypertensive patients with anti-AT1-receptor autoantibodies trial.
    Sun Y; Liao Y; Yuan Y; Feng L; Ma S; Wei F; Wang M; Zhu F
    J Am Soc Hypertens; 2014 Jan; 8(1):21-7. PubMed ID: 24131669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Candesartan versus imidapril in hypertension: a randomised study to assess effects of anti-AT1 receptor autoantibodies.
    Wei F; Jia XJ; Yu SQ; Gu Y; Wang L; Guo XM; Wang M; Zhu F; Cheng X; Wei YM; Zhou ZH; Fu M; Liao YH;
    Heart; 2011 Mar; 97(6):479-84. PubMed ID: 21296780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [AT1 receptor autoantibodies and essential hypertension].
    Liu H; Yang Y; Chen LL
    Hunan Yi Ke Da Xue Xue Bao; 2003 Jun; 28(3):255-8. PubMed ID: 14653082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin II antagonism and the heart: valsartan in left ventricular hypertrophy.
    Thürmann PA
    J Cardiovasc Pharmacol; 1999; 33 Suppl 1():S33-6; discussion S41-3. PubMed ID: 10028952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of combination of valsartan with benazepril on blood pressure and left ventricular hypertrophy in SHR.
    Ke YS; Cao H; Yang T
    Acta Pharmacol Sin; 2000 Nov; 21(11):1043-7. PubMed ID: 11501062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transforming growth factor beta1 genotype and change in left ventricular mass during antihypertensive treatment--results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA).
    Hallberg P; Lind L; Billberger K; Michaelsson K; Karlsson J; Kurland L; Kahan T; Malmqvist K; Ohman KP; Nyström F; Liljedahl U; Syvänen AC; Melhus H
    Clin Cardiol; 2004 Mar; 27(3):169-73. PubMed ID: 15049387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Study of autoantibodies against the G-protein-coupled beta 2- and alpha 1-adrenergic and AT1 receptors in patients with primary hypertension].
    Zhang L; Cui L; Miao GB; Zhao WS; Wang SY; Liu XL
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Aug; 24(4):367-9. PubMed ID: 12905654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular signaling mediated by angiotensin II type 1A receptor blockade leading to attenuation of renal dysfunction-associated heart failure.
    Li Y; Takemura G; Okada H; Miyata S; Maruyama R; Esaki M; Kanamori H; Li L; Ogino A; Ohno T; Kondo T; Nakagawa M; Minatoguchi S; Fujiwara T; Fujiwara H
    J Card Fail; 2007 Mar; 13(2):155-62. PubMed ID: 17395057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The angiotensin type 1 receptor antagonist valsartan attenuates pathological ventricular hypertrophy induced by hyperhomocysteinemia in rats.
    Kassab S; Garadah T; Abu-Hijleh M; Golbahar J; Senok S; Wazir J; Gumaa K
    J Renin Angiotensin Aldosterone Syst; 2006 Dec; 7(4):206-11. PubMed ID: 17318789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Autoantibodies against beta1 and M2 receptor in diabetic patients with refractory hypertension].
    Zhao LS; Liao YH; Xiang GD; Wang M; Zhou ZH; Hou J; Le L; Xu L
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 May; 34(5):407-10. PubMed ID: 16776952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoantibody against beta1-adrenergic receptor and left ventricular remodeling changes in response to metoprolol treatment.
    Miao GB; Liu JC; Liu MB; Wu JL; Zhang G; Chang J; Zhang L
    Eur J Clin Invest; 2006 Sep; 36(9):614-20. PubMed ID: 16919043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoantibodies against AT1-receptor and alpha1-adrenergic receptor in patients with hypertension.
    Liao YH; Wei YM; Wang M; Wang ZH; Yuan HT; Cheng LX
    Hypertens Res; 2002 Jul; 25(4):641-6. PubMed ID: 12358154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.